Allianz Asset Management
ACHV icon

Allianz Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Allianz Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-718
Closed -$182K – 2607
2018
Q1 		$182K Buy
+718
New +$205K ﹤0.01% 2581

Other funds holding ACHV

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Allianz Asset Management's ACHV Position: Q1 2016 in Review

Allianz Asset Management sold out of Achieve Life Sciences (ACHV) in Q1 2016, closing a stake of 329 shares — an estimated $869K sold.

Allianz Asset Management first reported a position in ACHV in Q2 2013 and held it in 11 quarters. The position peaked at $3.06M in Q1 2014. 38 funds tracked by Wall St. Rank hold ACHV as of Q1 2016.

  • Allianz Asset Management reported no remaining Achieve Life Sciences position as of Q1 2016 after selling out during the quarter.
  • Allianz Asset Management sold 329 Achieve Life Sciences shares in Q1 2016, an estimated $869K.
  • Allianz Asset Management first reported a position in Achieve Life Sciences in Q2 2013 and held it in 11 quarters.
  • Allianz Asset Management's Achieve Life Sciences position peaked at $3.06M in Q1 2014.
  • 38 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2016.

Based on Allianz Asset Management's 13F filing for Q1 2016, filed 13 May 2016.